Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The aminoglycosides.

P Duff1

  • 1Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville.

Obstetrics and Gynecology Clinics of North America
|September 1, 1992
PubMed
Summary
This summary is machine-generated.

Gentamicin, tobramycin, and amikacin are key aminoglycosides in obstetrics and gynecology, inhibiting bacterial protein synthesis. They treat infections but carry risks like kidney damage and hearing loss.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethnic equity in Aotearoa New Zealand's COVID-19 response: A descriptive epidemiological study.

Public health·2025
Same author

Poor working conditions and work stress among Canadian sex workers.

Occupational medicine (Oxford, England)·2017
Same author

Double Bond Position Plays an Important Role in Delta-9 Desaturation and Lipogenic Properties of Trans 18:1 Isomers in Mouse Adipocytes.

Lipids·2015
Same author

Isolation of α-linolenic acid biohydrogenation products by combined silver ion solid phase extraction and semi-preparative high performance liquid chromatography.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2015
Same author

Individual trans 18:1 isomers are metabolised differently and have distinct effects on lipogenesis in 3T3-L1 adipocytes.

Lipids·2014
Same author

Ambulatory postoperative ward-based epidural analgesia: a retrospective review of 1,147 cases.

Irish journal of medical science·2012
Same journal

Bridging Science and Practice in Gender-Affirming Care: A Compendium for Gynecologists.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evidence, Clinical Expertise, and Research Gaps in Gender-Affirming Care.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evaluation and Management of the Pediatric Gender-Diverse Patient.

Obstetrics and gynecology clinics of North America·2026
Same journal

Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.

Obstetrics and gynecology clinics of North America·2026
Same journal

Updates on Breast Cancer Screening and Special Considerations for Transgender Men and Women.

Obstetrics and gynecology clinics of North America·2026
Same journal

Contraceptive Needs of the Transmasculine Patient.

Obstetrics and gynecology clinics of North America·2026
See all related articles

Area of Science:

  • Pharmacology
  • Obstetrics & Gynecology
  • Infectious Disease

Background:

  • Aminoglycosides are crucial antibiotics in obstetric and gynecologic practice.
  • Commonly used agents include gentamicin, tobramycin, and amikacin.
  • These antibiotics target bacterial protein synthesis.

Purpose of the Study:

  • To review the role and characteristics of commonly used aminoglycosides in obstetrics and gynecology.
  • To outline their mechanism of action, spectrum of activity, and adverse effects.
  • To discuss their clinical applications in gynecologic and obstetric infections.

Main Methods:

  • Literature review of aminoglycoside antibiotics.
  • Analysis of their pharmacokinetic and pharmacodynamic properties.

Related Experiment Videos

  • Summary of clinical applications and adverse event profiles.

    • Main Results:

    • Aminoglycosides inhibit bacterial protein synthesis by binding to ribosomal subunits.
    • They exhibit primary activity against aerobic gram-negative bacilli.
    • Key adverse effects include nephrotoxicity, ototoxicity, and neuromuscular blockade.

    Conclusions:

    • Gentamicin, tobramycin, and amikacin are vital for treating serious obstetric and gynecologic infections.
    • Their use requires careful monitoring due to potential toxicities.
    • Often administered in combination therapy for conditions like pyelonephritis and pelvic inflammatory disease.